Qatar vs United Kingdom of Great Britain and Northern Ireland: Hepatitis B surface antigen (HBsAg) prevalence
Qatar
0.0%
in 2024
United Kingdom of Great Britain and Northern Ireland
0.0%
in 2024
Qatar rank
132nd
United Kingdom of Great Britain and Northern Ireland rank
132nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Qatar
- United Kingdom of Great Britain and Northern Ireland
How they compare
Qatar currently reports 0.0% against 0.0% in United Kingdom of Great Britain and Northern Ireland, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was United Kingdom of Great Britain and Northern Ireland ahead.
Qatar ranks 132nd and United Kingdom of Great Britain and Northern Ireland ranks 132nd of 194 countries.
Qatar has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Qatar | United Kingdom of Great Britain and Northern Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | Qatar |
| 2020s | 0.0% | 0.0% | 0.0% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Qatar or United Kingdom of Great Britain and Northern Ireland?
- Qatar, at 0.0% against 0.0% in United Kingdom of Great Britain and Northern Ireland as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Qatar and United Kingdom of Great Britain and Northern Ireland?
- 0.0%, with Qatar ahead.
- How many years of comparable data are there for Qatar and United Kingdom of Great Britain and Northern Ireland?
- 10 years are reported by both, from 2015 to 2024.
- How do Qatar and United Kingdom of Great Britain and Northern Ireland rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Qatar ranks 132nd and United Kingdom of Great Britain and Northern Ireland ranks 132nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.